New pill aims to boost testosterone in men with kidney disease
NCT ID NCT05249634
First seen Apr 30, 2026 · Last updated May 13, 2026 · Updated 2 times
Summary
This study is for men aged 18-85 with both low testosterone and moderate-to-severe chronic kidney disease. Researchers want to see if an oral testosterone pill called JATENZO can safely raise testosterone levels and improve red blood cell counts, muscle strength, and sexual function. The study involves blood tests, hand-grip strength measurements, and body scans over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Louis Univeristy
RECRUITINGSt Louis, Missouri, 63104, United States
Contact
Conditions
Explore the condition pages connected to this study.